Related Experiment Video
Updated: Oct 18, 2025

06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.1K
Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies
Timothy C Huber1, Teodora Bochnakova1, Yilun Koethe1
1Dotter Department of Interventional Radiology, Oregon Health and Science University, Portland, OR, USA.
Journal of Hepatocellular Carcinoma
|September 30, 2021
Abstract:
Percutaneous ablation is a mainstay of treatment for early stage, unresectable hepatocellular carcinoma (HCC). Recent advances in technology have created multiple ablative modalities for treatment of this common malignancy. The purpose of this review is to familiarize readers with the technical and clinical aspects of both existing and emerging percutaneous treatment options for HCC.
Keywords:
ablationcryoablationelectroporationhepatocellular carcinomamicrowavenanoparticlesradiofrequency
